Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Youn, Sihyun | - |
dc.contributor.author | Kim, Kyung Im | - |
dc.contributor.author | Ptacek, Jakub | - |
dc.contributor.author | Ok, Kiwon | - |
dc.contributor.author | Novakova, Zora | - |
dc.contributor.author | Kim, YunHye | - |
dc.contributor.author | Koo, JaeHyung | - |
dc.contributor.author | Barinka, Cyril | - |
dc.contributor.author | Byun, Youngjoo | - |
dc.date.available | 2017-07-11T04:41:09Z | - |
dc.date.created | 2017-04-10 | - |
dc.date.issued | 2015-11-15 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11750/2577 | - |
dc.description.abstract | Glutamate carboxypeptidase II (GCPII) is a zinc metalloprotease on the surface of astrocytes which cleaves N-acetylaspartylglutamate to release N-acetylaspartate and glutamate. GCPII inhibitors can decrease glutamate concentration and play a protective role against apoptosis or degradation of brain neurons. Herein, we report the synthesis and structural analysis of novel carborane-based GCPII inhibitors. We determined the X-ray crystal structure of GCPII in complex with a carborane-containing inhibitor at 1.79 Å resolution. The X-ray analysis revealed that the bulky closo-carborane cluster is located in the spacious entrance funnel region of GCPII, indicating that the carborane cluster can be further structurally modified to identify promising lead structures of novel GCPII inhibitors. © 2015 Elsevier Ltd. All rights reserved. | - |
dc.publisher | Elsevier Ltd | - |
dc.title | Carborane-containing urea-based inhibitors of glutamate carboxypeptidase II: Synthesis and structural characterization | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2015.09.062 | - |
dc.identifier.scopusid | 2-s2.0-84945917753 | - |
dc.identifier.bibliographicCitation | Bioorganic and Medicinal Chemistry Letters, v.25, no.22, pp.5232 - 5236 | - |
dc.subject.keywordAuthor | Carborane | - |
dc.subject.keywordAuthor | Glutamate carboxypeptidase II | - |
dc.subject.keywordAuthor | X-ray crystal structure | - |
dc.subject.keywordPlus | ANALOGS | - |
dc.subject.keywordPlus | Analogs and Derivatives | - |
dc.subject.keywordPlus | Antagonists and Inhibitors | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | BORON | - |
dc.subject.keywordPlus | Boron Compounds | - |
dc.subject.keywordPlus | Boron Derivative | - |
dc.subject.keywordPlus | Carborane | - |
dc.subject.keywordPlus | Carborane Derivative | - |
dc.subject.keywordPlus | Chemistry | - |
dc.subject.keywordPlus | Controlled Study | - |
dc.subject.keywordPlus | Crystal Structure | - |
dc.subject.keywordPlus | Crystallography, X-Ray | - |
dc.subject.keywordPlus | DERIVATIVES | - |
dc.subject.keywordPlus | Drug Synthesis | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | Enzyme Inhibitor | - |
dc.subject.keywordPlus | Enzyme Inhibitors | - |
dc.subject.keywordPlus | Fluorescence | - |
dc.subject.keywordPlus | Glutamate Carboxypeptidase II | - |
dc.subject.keywordPlus | Glutamate Carboxypeptidase II Inhibitor | - |
dc.subject.keywordPlus | Human | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Hydrogen Bond | - |
dc.subject.keywordPlus | MemBRANE ANTIGEN PSMA | - |
dc.subject.keywordPlus | NEUTRON-CAPTURE THERAPY | - |
dc.subject.keywordPlus | PHARMACOPHORE | - |
dc.subject.keywordPlus | PROGESTERONE-RECEPTor ANTAGONISTS | - |
dc.subject.keywordPlus | PROSTATE-CANCER | - |
dc.subject.keywordPlus | Structure Analysis | - |
dc.subject.keywordPlus | Synthesis | - |
dc.subject.keywordPlus | Ultrastructure | - |
dc.subject.keywordPlus | Urea | - |
dc.subject.keywordPlus | X-Ray Crystal Structure | - |
dc.subject.keywordPlus | X Ray Crystallography | - |
dc.citation.endPage | 5236 | - |
dc.citation.number | 22 | - |
dc.citation.startPage | 5232 | - |
dc.citation.title | Bioorganic and Medicinal Chemistry Letters | - |
dc.citation.volume | 25 | - |
There are no files associated with this item.